Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2000
11/28/2000US6153187 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
11/28/2000CA2308259A1 Method for assaying the function of flaa1 and wbpm
11/28/2000CA2305716A1 Method for assay of wbpm
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA2032253C 5-lipoxygenase activating protein
11/23/2000WO2000070094A1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070023A1 Novel fab fragment libraries and methods for their use
11/23/2000WO2000069915A2 COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES
11/23/2000WO2000069914A2 Humanized antibodies specific for egp-2
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069907A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069886A2 Oligomeric chaperone proteins
11/23/2000WO2000069879A2 Ca7 cg04 gene
11/23/2000WO2000069463A1 Compositions and methods for treating cell proliferation disorders
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000069461A1 Antibody vaccine for autoimmune diseases
11/23/2000WO2000069460A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
11/23/2000WO2000069459A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
11/23/2000WO2000069454A1 Suppression of endogenous igfbp-2 to inhibit cancer
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000030681A9 Antagonists of the alpha e beta 7 integrin as therapeutic agents for inflammatory diseases
11/23/2000WO2000029556A3 Identification of glycosphingolipids that promote hiv-1 entry into cells
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000022144A3 Means and methods for modulating stomata characteristica in plants
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO2000004863A3 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions
11/23/2000DE19926879A1 Detecting, isolating or quantifying basophils, mast cells and their precursors for diagnosing e.g. leukemia, comprises using antibodies
11/23/2000DE19923168A1 Neue Fluoreszenzfarbstoffe und ihre Verwendung als Fluoreszenzmarker New fluorescent dyes and their use as fluorescent markers
11/23/2000DE19919124A1 Nukleinsäuremolekül, umfassend eine für ein Polypeptid mit Chorismatmutase-Aktivität kodierende Nukleinsäure Nucleic acid molecule comprising a sequence encoding a polypeptide having chorismate mutase activity nucleic acid
11/23/2000CA2374085A1 Tumour treatment with anti-erbb2 antibodies
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2373938A1 Compositions and methods for treating cell proliferation disorders
11/23/2000CA2373815A1 Treatment of refractory human tumors with epidermal growth factor receptor antagonists
11/23/2000CA2373616A1 Tm4sf receptors
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372582A1 Novel fab fragment libraries and methods for their use
11/23/2000CA2372549A1 Ox2 receptor homologs
11/23/2000CA2372541A1 Sphingosine kinase enzyme
11/23/2000CA2372304A1 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000CA2372200A1 Self-assembling biomolecular structures
11/23/2000CA2372199A1 Oligomeric chaperone proteins
11/23/2000CA2372198A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000CA2372119A1 Neuroprotective properties of gdf-15, a novel member of the tgf-.beta. superfamily
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2369397A1 Combined approach to treatment of cancer with hcg vaccines
11/23/2000CA2369369A1 Buforin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/22/2000EP1054059A1 Novel cDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation
11/22/2000EP1054039A1 Fluorescent dyes and their use as fluorescent labelling agents
11/22/2000EP1054018A1 Fab fragment libraries and methods for their use
11/22/2000EP1053751A1 Compositions and methods for treating cell proliferation disorders
11/22/2000EP1053473A1 Method and apparatus for detecting conception in animals
11/22/2000EP1053351A1 Novel molecules of the tnf receptor superfamily and uses therefor
11/22/2000EP1053342A2 Nucleic acid delivery vehicles
11/22/2000EP1053332A1 Protein
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053324A1 Novel cystine knot protein and materials and methods for making it
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053322A1 Wnt-10a
11/22/2000EP1053321A1 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
11/22/2000EP1053320A2 Human transport-associated molecules
11/22/2000EP1053319A2 Human genes and gene expression products ii
11/22/2000EP1053318A2 Cdnas encoding secreted proteins
11/22/2000EP1053308A1 Dendritic enriched secreted lymphocyte activation molecule
11/22/2000EP1053307A1 Podocalyxin like sialomucins having selectin ligand activity
11/22/2000EP1053256A1 Antibodies to death receptor 4 (dr4) and uses thereof
11/22/2000EP1053254A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
11/22/2000EP1053251A1 The aiolos gene
11/22/2000EP1053245A1 45 human secreted proteins
11/22/2000EP1053010A1 Copolymer compositions for oral delivery
11/22/2000EP1053009A2 Use of heregulin as an epithelial cell growth factor
11/22/2000EP1053006A1 Costimulatory blockade and mixed chimerism in transplantation
11/22/2000EP0866717A4 Oligodendrocyte-specific protein and method for treating disease
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1274007A Process for preparing Se-contained humanized abzyme
1 ... 1142 1143 1144 1145 1146 1147 1148 1149 1150 1151 1152 1153 1154 1155 1156 1157 1158 1159 1160 1161 1162 ... 1494